News Conference News HVS 2025 Solid Durability Seen With Surgical Resilia Tissue Aortic Valve Yael L. Maxwell April 21, 2025
News Daily News COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year Todd Neale April 11, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Daily News Reinterventions Rare Yet Predictable After TAVI, French Registries Show Caitlin E. Cox March 05, 2025
News Daily News Patient-Centric Outcomes Embraced by Global Heart Valve Experts L.A. McKeown February 24, 2025
News Daily News ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER Caitlin E. Cox February 14, 2025
News Daily News Downsizing, Underexpansion Common in Redo TAVI With Sapien 3 Todd Neale December 20, 2024
News Conference News PCR London Valves 2024 Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years Michael O'Riordan November 27, 2024
News Conference News PCR London Valves 2024 Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia Michael O'Riordan November 26, 2024
News Conference News TCT 2024 Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick Yael L. Maxwell November 07, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
Presentation TCT 2024 Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials Presenter: Mahesh Madhavan October 30, 2024
Presentation TCT 2024 Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients Presenter: Julien Ternacle October 30, 2024
Presentation TCT 2024 Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability Presenter: Philippe Pibarot October 30, 2024
Presentation TCT 2024 Lessons Learned From the SMART Trial Presenter: Howard Herrmann October 30, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024